Table 2.
Cox proportional hazards regression models for PFS and OS in the entire study population.
PFS | OS | |||||||
---|---|---|---|---|---|---|---|---|
Univariable models | Multivariable model | Univariable models | Multivariable model | |||||
Characteristics | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P |
Age (years) | — | 0.412 | — | — | — | 0.813 | — | — |
<70 | Ref | — | — | — | Ref | — | — | — |
≥70 | 1.31 (0.69–2.48) | — | — | — | 1.09 (0.52–2.28) | — | — | — |
Sex | — | 0.798 | — | — | — | 0.508 | — | — |
Female | Ref | — | — | — | Ref | — | — | — |
Male | 0.93 (0.56–1.56) | — | — | — | 0.81 (0.44–1.50) | — | — | — |
ECOG PS | — | 0.001 | — | 0.026 | — | <0.001 | — | <0.001 |
0 | Ref | — | Ref | — | Ref | — | Ref | — |
≥1 | 2.39 (1.42–4.03) | — | 1.88 (1.08–3.29) | — | 3.32 (1.82–6.06) | — | 3.04 (1.65–5.59) | — |
Primary tumor location | — | 0.247 | — | — | — | 0.630 | — | — |
Right | Ref | — | — | — | Ref | — | — | — |
Left colon/Rectum | 0.54 (0.19–1.52) | — | — | — | 0.75 (0.23–2.43) | — | — | — |
Primary tumor resection | — | 0.498 | — | — | — | 0.453 | — | — |
No | Ref | — | — | — | Ref | — | — | — |
Yes | 0.80 (0.41–1.54) | — | — | — | 1.31 (0.64–2.69) | — | — | — |
Adjuvant CT | — | 0.449 | — | — | — | 0.560 | — | — |
No | Ref | — | — | — | Ref | — | — | — |
Yes | 1.22 (0.73–2.06) | — | — | — | 0.83 (0.44–1.56) | — | — | — |
Metastatic sites (N) | — | 0.487 | — | — | — | 0.218 | — | — |
1 | Ref | — | — | — | Ref | — | — | — |
>1 | 1.23 (0.68–2.22) | — | — | — | 1.62 (0.75–3.51) | — | — | — |
Prior treatment lines | — | 0.288 | — | — | — | 0.065 | — | — |
1–2 | Ref | — | — | — | Ref | — | — | — |
≥3 | 1.32 (0.79–2.20) | — | — | — | 1.79 (0.96–3.31) | — | — | — |
PRESSING-HER2 | — | <0.001 | — | 0.005 | — | <0.001 | — | 0.007 |
Negative | Ref | — | Ref | — | Ref | — | Ref | — |
Positive | 3.49 (1.74–6.99) | — | 3.06 (1.40–6.69) | — | 3.79 (1.78–8.07) | — | 2.93 (1.32–6.48) | — |
HER CNV | — | <0.001 | — | 0.002 | — | 0.157 | — | — |
≥6 | Ref | — | Ref | — | Ref | — | — | — |
<6 | 4.63 (1.97–10.92) | — | 3.89 (1.60–9.49) | — | 1.87 (0.79–4.46) | — | — | — |
Abbreviations: CT, chemotherapy; Ref, reference.